In acute lymphoblastic leukemia, CD9 expression was associated with a poor prognosis [18] as well as its overexpression in an aggressive tumor like esophageal squamous cell correlated with tumor clinical staging and lymph node involvement [19]. This evidence concerns the gene CD9 and neoplasm.